3-methylcytosine has been researched along with 1-methyladenosine in 1 studies
| Studies (3-methylcytosine) | Trials (3-methylcytosine) | Recent Studies (post-2010) (3-methylcytosine) | Studies (1-methyladenosine) | Trials (1-methyladenosine) | Recent Studies (post-2010) (1-methyladenosine) |
|---|---|---|---|---|---|
| 23 | 0 | 8 | 108 | 0 | 58 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Aas, PA; Bjørås, M; Erlandsen, HO; Fonseca, DM; Hagen, L; Iveland, TS; Mosammaparast, N; Palibrk, V; Rabe, R; Sharma, A; Slupphaug, G; Sporsheim, B; Vågbø, CB; Wollen, KL | 1 |
1 other study(ies) available for 3-methylcytosine and 1-methyladenosine
| Article | Year |
|---|---|
ALKBH3 partner ASCC3 mediates P-body formation and selective clearance of MMS-induced 1-methyladenosine and 3-methylcytosine from mRNA.
Topics: Adenosine; AlkB Homolog 3, Alpha-Ketoglutarate-Dependent Dioxygenase; Animals; Cytosine; DNA Helicases; Humans; Ribosomes; RNA Helicases; RNA, Messenger; Transcription Factors; Tripartite Motif Proteins; Ubiquitin-Protein Ligases | 2021 |